VCLIP Post-Market Study, Long-term Follow-up on LAA Exclusion Using AtriClip
Completed · Not applicable
Conditions studied: Left Atrial Appendage Absent
In brief
Retrospective-prospective, multi-center, non-randomized, unblinded, post-market study to evaluate the long-term performance and safety of AtriClip® FLEX-V LAA and PRO•V LAA Exclusion devices for exclusion of the left atrial appendage of the heart during concomitant cardiac procedures.
Key facts
- Study ID
- NCT05101993
- Run by
- AtriCure, Inc.
- People needed
- 156
- Starts
- 2022-01-27
- Expected to finish
- 2024-07-22
- Last updated by the study team
- 2025-07-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Subject is greater than or equal to 18 years of age.
- Subject who received the AtriClip FLEX-V or PRO•V implant during a non-emergent cardiac surgical procedure
- Subject is willing and able to provide written informed consent
- Subject is willing and able to return for scheduled follow-up visit and imaging (CTA or TEE)
You may not qualify if…
- Inability, unwillingness, or contraindication to undergo TEE or CTA imaging
- Subjects who are pregnant or breast feeding
- Subjects with active COVID-19 infection
Where it is running
- Franciscan Health — Indianapolis, Indiana, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Albany Medical College — Albany, New York, United States
- NYU — New York, New York, United States
- Mount Sinai — New York, New York, United States
- Columbia University — New York, New York, United States
- Mercy Health Cincinnati — Cincinnati, Ohio, United States
- Toledo Hospital — Toledo, Ohio, United States
- Prisma Health — Greenville, South Carolina, United States
- Centra Lynchburg General Hospital — Lynchburg, Virginia, United States
- Aurora Research Institute LLC — Milwaukee, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.